Deerfield Management Company, L.P. (Series C) Nevro Corp Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.56 - $20.78 $164,550 - $252,165	12,135 New	12,135 $175,000
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $12.9 Million - $19.9 Million	-216,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $17.5 Million - $26.2 Million	216,000 New	216,000 $17.5 Million
Q3 2019 Nov 14, 2019	SELL	$61.52 - $91.1 $23.7 Million - $35.2 Million	-386,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$58.04 - $66.99 $11.2 Million - $13 Million	-193,463 Reduced 33.39%	386,000 $25 Million
Q1 2019 May 15, 2019	SELL	$35.52 - $62.62 $11.9 Million - $21 Million	-334,810 Reduced 36.62%	579,463 $36.2 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $13.8 Million - $21.9 Million	389,233 Added 74.13%	914,273 $35.6 Million
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $23.2 Million - $39.6 Million	525,040 New	525,040 $29.9 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$16.6 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$14.1 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$13.6 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$9.21 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$7.9 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account